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Insulin resistance and depressive symptoms in middle
aged men: findings from the Caerphilly prospective
cohort study
Debbie A Lawlor, Yoav Ben-Shlomo, Shah Ebrahim, George Davey Smith, Stephen A Stansfeld,
John W G Yarnell, John E J Gallacher
Insulin resistance may protect against depression,
possibly through an effect on circulating free fatty
acid concentrations and brain serotonin concentra-
tion,1 2 although a recent study contradicted these
findings.3 Studies to date have either used indirect
measures of insulin resistance,1 or they have been
cross sectional.2 3 We assessed the association of insu-
lin resistance with depressive symptoms in a prospec-
tive cohort.
Participants, methods, and results
The Caerphilly cohort study has been described in
detail before.4 In phase I (1979-83), 2512 (89% of eligi-
ble) men aged 45-59 years from Caerphilly in Wales
provided fasting blood samples. Insulin resistance
(homoeostasis model assessment (HOMA) score) was
derived from fasting insulin and glucose.5 HOMA
scores were not calculated for men with diabetes or
high fasting glucose ( ≥ 7.0 mmol/l).
In phases II (1984-88), III (1989-93), and IV (1993-
7), depressive symptoms were measured by the 30 item
general household questionnaire (GHQ). This was
validated at phase II in a subgroup (n = 97) by
comparison with a clinical interview schedule given by
a psychiatrist blinded to the GHQ score.4 Based on
receiver operating characteristics, we defined men
scoring five or above as having mild to moderate
psychological distress.4
At phase I, 2203 (88%) of the men had assessment
of insulin resistance or diabetes status. Of the surviving
men, the numbers with GHQ data at phases II, III, and
IV were 1619/2025 (80%), 1236/1845 (67%), and
1088/1675 (65%).
Insulin resistance and high GHQ score were not
associated at any phase of follow up (table). Diabetes at
baseline was associated with a tendency to reduced
odds of high GHQ at follow up, but, owing to small
numbers, these estimates are imprecise. Additional
adjustment for smoking, physical activity, alcohol con-
sumption, and adult and childhood social class did not
substantively alter any of the findings.
Insulin resistance and GHQ scores were not associ-
ated in linear regression models with GHQ as a
continuous outcome (all P values > 0.2). When fasting
insulin was used there was no evidence of an
association with GHQ. In cross sectional analyses
(exposures and outcomes measured at phase II) there
was no association between any HOMA scores, fasting
insulin, or diabetes and GHQ score. We also found no
associations between body mass index, systolic blood
pressure, high density lipoprotein cholesterol, or
(logged) triglyceride concentration and GHQ in either
prospective or cross sectional analyses (all P values
> 0.3).
Comment
Insulin resistance was not associated with reduced
depressive symptoms in a prospective study of middle
aged men. This contradicts our earlier findings in a
cross sectional study of older women, in which there
was an inverse association with both clinically
diagnosed depression and use of antidepressant
drugs,2 and the findings of a second cross sectional
study which found a positive association between insu-
lin resistance and depression assessed using the Beck’s
depression inventory.3 These contradictory findings
may be due to the cross sectional nature of the earlier
studies. A large prospective study, in which reverse cau-
sality would be unlikely, found that indicators of insulin
sensitivity were associated with suicide risk.1 Taken
together these findings indicate that insulin resistance
may protect against only severe depression.
This article was posted on bmj.com on 31 January 2005: http://bmj.com/
cgi/doi/10.1136/bmj.38377.616921.F7
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Our assessment of depression was based on GHQ
rather than clinical assessment, and if insulin resistance
is only protective against severe depression then this
measure may be inadequate to detect an association.
Also, any measurement error in our assessment of
depression would tend to dilute the results. We
validated the score, however, against a clinical interview
in a subgroup.4
The contradictory results concerning the associa-
tion of insulin resistance with depression and suicide
warrant further research. Future studies might include
trials of the effects on insulin resistance of treating
depression. Observational studies should ideally use
standardised diagnostic criteria for depression and
prospectively assess the association of insulin resist-
ance with differing severities.
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What is already known on this topic
Cross sectional studies and those using indirect
measurements indicate that insulin resistance may
protect against depression
What this study adds
Insulin resistance was not associated with reduced
depressive symptoms in a prospective study of
middle aged men
Insulin resistance and diabetes at baseline (1979-83) and GHQ score (indicative of depressive symptoms) at different phases of follow
up in middle aged men in the Caerphilly prospective cohort study
Phase of follow up High GHQ* at all three follow
up phasesII III IV
Median no of years from
baseline
5 10 14 14
No with GHQ data 1619 1236 1088 944
No with high GHQ 362 289 271 63
Age and time of blood
sampling adjusted
prevalence of high GHQ
score by insulin resistance
or diabetes (% (95% CI)):
Lowest fourth HOMA 22.9 (19.1 to 27.2) 21.7 (17.4 to 26.7) 24.1 (19.5 to 29.4) 7.9 (5.1 to 12.0)
2nd fourth HOMA 21.4 (17.7 to 25.7) 22.2 (18.0 to 27.2) 21.6 (17.0 to 27.0) 4.3 (2.4 to 7.6)
3rd fourth HOMA 24.6 (20.6 to 29.1) 23.7 (19.2 to 28.9) 27.0 (21.9 to 32.7) 6.7 (4.1 to 10.7)
Highest fourth HOMA 20.5 (16.7 to 25.0) 26.9 (22.1 to 32.4) 28.8 (23.4 to 34.9) 7.3 (4.4 to 11.9)
Diabetes or high fasting
glucose
19.5 (11.1 to 31.9) 16.3 (7.5 to 31.8) 12.3 (4.7 to 28.5) 4.0 (0.6 to 2.3)
Age and time of sampling
adjusted odds ratio (95%
CI) per increase of one
quarter HOMA distribution†
0.97 (0.87 to 1.08) 1.09 (0.96 to 1.22) 1.09 (0.96 to 1.23) 0.97 (0.77 to 1.23)
Age and time of sampling
adjusted odds ratio (95%
CI) comparing those with
diabetes or high glucose to
those without‡
0.64 (0.30 to 1.38) 0.62 (0.25 to 1.50) 0.40 (0.14 to 1.18) 0.59 (0.08 to 4.39)
Age and time of sampling
adjusted odds ratio (95%
CI) comparing those with
clinical diagnosis of diabetes
to those without§
0.84 (0.61 to 1.14) 1.02 (0.83 to 1.22) 0.88 (0.68 to 1.14) 0.61 (0.16 to 2.38)
GHQ=general household questionnaire; HOMA=homoeostasis model assessment
*To calculate adjusted prevalence of high GHQ scores we used logistic regression models with the covariates age and time of blood sampling included as
continuous variables centred around their mean values (that is, age in years minus mean age in years for the sample and time of sampling in 10 minute intervals
minus mean time for the sample. Blood samples were taken between 8 am and 7 pm).
†Odds ratio of high GHQ per increase in one fourth of HOMA distribution among only those with no evidence (diagnosis or high fasting glucose ≥7.0 mmol/l) of
diabetes.
‡Odds ratio comparing those with either a clinical diagnosis of diabetes or high fasting glucose (≥7.0 mmol/l) with all others.
§Odds ratio comparing those with a clinical diagnosis of diabetes with all others (irrespective of fasting glucose level).
Papers
Department of
Epidemiology,
Statistics and Public
Health, University
of Wales College of
Medicine
John E J Gallacher
senior lecturer in
environmental
epidemiology
Correspondence to:
D A Lawlor
d.a.lawlor@
bristol.ac.uk
706 BMJ VOLUME 330 26 MARCH 2005 bmj.com
